During the past decade, Midwest Institute for Clinical Research conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 26 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 17 clinical trials were completed. i.e. 170% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midwest Institute for Clinical Research" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 8 trials sponsored, "NewAmsterdam Pharma" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midwest Institute for Clinical Research" #1 collaborator was "Medpace, Inc." with 2 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Midwest Institute for Clinical Research" are "Hypercholesterolemia" (7 trials), "Hyperlipidemia" (6 trials), "Hypertension" (6 trials), "Atherosclerotic Cardiovascular Disease" (4 trials) and "Dyslipidemias" (3 trials). Many other conditions were trialed in "Midwest Institute for Clinical Research" in a lesser frequency.

Most popular intervention types in "Midwest Institute for Clinical Research" are "Drug" (42 trials), "Other" (6 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Obicetrapib" (3 trials), "Aprocitentan 25 mg" (2 trials), "Atorvastatin" (2 trials) and "Fenofibrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Institute for Clinical Research" are 46 trials for "All" genders.

Currently, there are NaN active trials in "Midwest Institute for Clinical Research". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Midwest Institute for Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Institute for Clinical Research, 0 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".